These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 29614006)

  • 1. Rapid CRISPR/Cas9-Mediated Cloning of Full-Length Epstein-Barr Virus Genomes from Latently Infected Cells.
    Yajima M; Ikuta K; Kanda T
    Viruses; 2018 Apr; 10(4):. PubMed ID: 29614006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly Efficient CRISPR/Cas9-Mediated Cloning and Functional Characterization of Gastric Cancer-Derived Epstein-Barr Virus Strains.
    Kanda T; Furuse Y; Oshitani H; Kiyono T
    J Virol; 2016 May; 90(9):4383-93. PubMed ID: 26889033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A global phylogenetic analysis of Japanese tonsil-derived Epstein-Barr virus strains using viral whole-genome cloning and long-read sequencing.
    Yajima M; Kakuta R; Saito Y; Kitaya S; Toyoda A; Ikuta K; Yasuda J; Ohta N; Kanda T
    J Gen Virol; 2021 Mar; 102(3):. PubMed ID: 33433312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutagenesis and Genome Engineering of Epstein-Barr Virus in Cultured Human Cells by CRISPR/Cas9.
    Yuen KS; Chan CP; Kok KH; Jin DY
    Methods Mol Biol; 2017; 1498():23-31. PubMed ID: 27709566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential Application of the CRISPR/Cas9 System against Herpesvirus Infections.
    Chen YC; Sheng J; Trang P; Liu F
    Viruses; 2018 May; 10(6):. PubMed ID: 29844277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of Epstein-Barr virus DNA load in latently infected nasopharyngeal carcinoma cells by CRISPR/Cas9.
    Yuen KS; Wang ZM; Wong NM; Zhang ZQ; Cheng TF; Lui WY; Chan CP; Jin DY
    Virus Res; 2018 Jan; 244():296-303. PubMed ID: 28456574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr Virus BKRF4 Gene Product Is Required for Efficient Progeny Production.
    Masud HMAA; Watanabe T; Yoshida M; Sato Y; Goshima F; Kimura H; Murata T
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28904200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Gene modification in the genome of Epstein-Barr virus cloned as a bacterial artificial chromosome].
    Lu J; Tang Y; Zhou M; Wu M; Ouyang J; Gao J; Zhang L; Li D; Chen Q; Xiong W; Li X; Tang K; Li G
    Wei Sheng Wu Xue Bao; 2008 Mar; 48(3):385-90. PubMed ID: 18479068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and Cloning of a New Western Epstein-Barr Virus Strain That Efficiently Replicates in Primary B Cells.
    Delecluse S; Poirey R; Zeier M; Schnitzler P; Behrends U; Tsai MH; Delecluse HJ
    J Virol; 2020 May; 94(10):. PubMed ID: 32102884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR/Cas9-Mediated Genome Editing of Herpesviruses Limits Productive and Latent Infections.
    van Diemen FR; Kruse EM; Hooykaas MJ; Bruggeling CE; Schürch AC; van Ham PM; Imhof SM; Nijhuis M; Wiertz EJ; Lebbink RJ
    PLoS Pathog; 2016 Jun; 12(6):e1005701. PubMed ID: 27362483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of viral recombinants to the study of the immune response against the Epstein-Barr virus.
    Delecluse HJ; Feederle R; Behrends U; Mautner J
    Semin Cancer Biol; 2008 Dec; 18(6):409-15. PubMed ID: 18938248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early Epstein-Barr Virus Genomic Diversity and Convergence toward the B95.8 Genome in Primary Infection.
    Weiss ER; Lamers SL; Henderson JL; Melnikov A; Somasundaran M; Garber M; Selin L; Nusbaum C; Luzuriaga K
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29093087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From Conventional to Next Generation Sequencing of Epstein-Barr Virus Genomes.
    Kwok H; Chiang AK
    Viruses; 2016 Feb; 8(3):60. PubMed ID: 26927157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A precise excision of the complete Epstein-Barr virus genome in a plasmid based on a bacterial artificial chromosome.
    Yu Z; Lu J; Yu H; Yan Q; Zuo L; Li G
    J Virol Methods; 2011 Sep; 176(1-2):103-7. PubMed ID: 21723326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unexpected instability of family of repeats (FR), the critical cis-acting sequence required for EBV latent infection, in EBV-BAC systems.
    Kanda T; Shibata S; Saito S; Murata T; Isomura H; Yoshiyama H; Takada K; Tsurumi T
    PLoS One; 2011; 6(11):e27758. PubMed ID: 22114684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early events associated with infection of Epstein-Barr virus infection of primary B-cells.
    Halder S; Murakami M; Verma SC; Kumar P; Yi F; Robertson ES
    PLoS One; 2009 Sep; 4(9):e7214. PubMed ID: 19784370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of Epstein-Barr Virus Genomes and Expression Profiles in Gastric Adenocarcinoma.
    Borozan I; Zapatka M; Frappier L; Ferretti V
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29093097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phylogenetic comparison of Epstein-Barr virus genomes.
    Choi SJ; Jung SW; Huh S; Cho H; Kang H
    J Microbiol; 2018 Aug; 56(8):525-533. PubMed ID: 29948828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation and precise modification of a herpesvirus saimiri bacterial artificial chromosome demonstrates that the terminal repeats are required for both virus production and episomal persistence.
    White RE; Calderwood MA; Whitehouse A
    J Gen Virol; 2003 Dec; 84(Pt 12):3393-3403. PubMed ID: 14645920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly efficient CRISPR-Cas9-mediated gene knockout in primary human B cells for functional genetic studies of Epstein-Barr virus infection.
    Akidil E; Albanese M; Buschle A; Ruhle A; Pich D; Keppler OT; Hammerschmidt W
    PLoS Pathog; 2021 Apr; 17(4):e1009117. PubMed ID: 33857265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.